- Home
- ZYXI vs IKNA Comparison
ZYXI vs IKNA Comparison
Compare ZYXI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- IKNA
- Stock Information
- Founded
- ZYXI 1996
- IKNA 2016
- Country
- ZYXI United States
- IKNA United States
- Employees
- ZYXI N/A
- IKNA N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- IKNA Health Care
- Exchange
- ZYXI Nasdaq
- IKNA Nasdaq
- Market Cap
- ZYXI 72.3M
- IKNA 63.7M
- IPO Year
- ZYXI N/A
- IKNA 2021
- Fundamental
- Price
- ZYXI $2.39
- IKNA $1.33
- Analyst Decision
- ZYXI Buy
- IKNA Strong Buy
- Analyst Count
- ZYXI 3
- IKNA 1
- Target Price
- ZYXI $6.00
- IKNA $4.00
- AVG Volume (30 Days)
- ZYXI 257.6K
- IKNA 55.6K
- Earning Date
- ZYXI 07-24-2025
- IKNA 08-07-2025
- Dividend Yield
- ZYXI N/A
- IKNA N/A
- EPS Growth
- ZYXI N/A
- IKNA N/A
- EPS
- ZYXI N/A
- IKNA N/A
- Revenue
- ZYXI $172,401,000.00
- IKNA N/A
- Revenue This Year
- ZYXI N/A
- IKNA N/A
- Revenue Next Year
- ZYXI $19.55
- IKNA N/A
- P/E Ratio
- ZYXI N/A
- IKNA N/A
- Revenue Growth
- ZYXI N/A
- IKNA N/A
- 52 Week Low
- ZYXI $1.66
- IKNA $0.97
- 52 Week High
- ZYXI $10.62
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- ZYXI 48.86
- IKNA 52.15
- Support Level
- ZYXI $2.31
- IKNA $1.31
- Resistance Level
- ZYXI $2.72
- IKNA $1.42
- Average True Range (ATR)
- ZYXI 0.18
- IKNA 0.04
- MACD
- ZYXI -0.01
- IKNA -0.01
- Stochastic Oscillator
- ZYXI 17.31
- IKNA 27.27
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.